Salts of benzimidazole compound and use thereof

Details Salts of benzimidazole compound and use thereof Salts of benzimidazole compound and use thereof

2007-09-18

2007-09-18

Morris, Patricia L. (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C546S273700

Reexamination Certificate

active

10343142

ABSTRACT:
A sodium salt, magnesium salt, lithium salt, potassium salt, calcium salt or barium salt of (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole, and a pharmaceutical composition comprising the salt. The novel salt is useful as an excellent antiulcer agent.

REFERENCES:
patent: 6002011 (1999-12-01), Kato et al.
patent: 6124464 (2000-09-01), Hogberg et al.
patent: 6462058 (2002-10-01), Fujishima et al.
patent: 1 277 752 (2003-01-01), None
patent: 61-50978 (1986-03-01), None
patent: 2003/0153766 (2003-08-01), None
patent: WO92/08716 (1992-05-01), None
patent: WO94/27988 (1994-12-01), None
patent: WO96/02535 (1996-02-01), None
patent: WO97/41114 (1997-11-01), None
patent: WO99/27917 (1999-06-01), None
patent: 99/38513 (1999-08-01), None
patent: WO99/38513 (1999-08-01), None
patent: WO 00/78745 (2000-12-01), None
patent: WO 01/14366 (2001-03-01), None
patent: WO 01/87874 (2001-11-01), None
Kotar et a., Eur. J of Pharm, Sci., 4 (1996) pp. S182.
Brittain, Polymorphism in Pharmaceutical Sciences, NY: Marcel Dekker, Inc. (1999) pp. 126-358.
Chemical & Engineering News, Feb. 2003, pp. 32-35.
US Pharmacopia, 1995, pp. 1843-1844.
Concise Encyclopedia Chemistry, pp. 872-873 (1993).
Buck, G., et al., “Relation ofCampylobacter pylordisto Gastritis and Peptic Ulcer”, The Journal of Infectious Diseases, (1986), vol. 153, No. 4, pp. 664-669.
Hopkins, R., et al., “Relationship BetweenHelicobacter pyloriEradication and Reduced Duodenal and Gastric Ulcer Recurrence: A Review”, Gastroenterology, (1996), vol. 110, No. 4, pp. 1244-1252.
Laine, L., et al., “Has the Impact ofHelicobacter pyloriTherapy on Ulcer Recurrence in the United States been Overstated?” The American Journal of Gastroeneterology, (1998), vol. 93, No. 9, pp. 1409-1415.
Katoh, M., et al., “Clinical Efficacy of Lansoprazole in Eradication ofHelicobacter pylori”, J. Clin Gastroenterol, (1995), vol. 20, Suppl. 2, pp. S112-S114.
Sugiyama, T., et al., “Lansoprazole versus Lansoprazole plus Amoxicillin treatment for Eradication ofHelicobacter pyloriin Patients with Gastric Ulcer”, J. Clin Gastroenterol, (1995), vol. 20, Suppl. 2, pp. S104-S106.
Takimoto, T., et al., “Efficacy of Lansoprazole in Eradication ofHelicobacter pylori”, J. Clin Gastroenterol, (1995), vol. 20, Suppl. 2, pp. S121-S124.
Ogoshi, K., et al., “Peptic Ulcer Therapy with Lansoprazole andHelicobacter pyloriEradication”, J. Clin Gastroenterol, (1995), vol. 20, Suppl. 2, pp. S97-S99.
Iwahi, T., et al., “Lansoprazole, a Novel Benzimidazole Proton Pump Inhibitor, and its Related Compounds have Selective Activity againstHelicobacter pylori”, Antimicrobial Agents and Chemotherapy, (1991), vol. 35, No. 3, pp. 490-496.
Nakao, M., et al., “Antibacterial Properties of Lansoprazole alone and in Combination with Antimicrobial Agents againstHelicobacter pylori”, Eur. J. Clin. Microbiol. Infect. Dis., (1995), vol. 14, No. 5, pp. 391-399.
Alarcon, T., et al., “In Vitro Activity of Ebrotidine, Ranitidine, Omeprazole, Lansoprazole, and Bismuth Citrate against Clinical Isolates ofHelicobacter pylori”, Eur. J. Clin. Microbiol. Infect. Dis., (1998), vol. 17, pp. 275-277.
Vogt, K., et al., “Bactericidal Activity of Lansoprazole and Omeprazole againstHelicobacter pyloriin vitro”, Arzneim.-Forsch./Drug Res. 48, (1998), No. 6, pp. 694-697.
Nakao, M., et al., “Growth Inhibitory and Bactericidal Activities of Lansoprazole Compared with those of Omeprazole and Pantoprazole againstHelicobacter pylori”, Helicobacter, (1998), vol. 3, No. 1, pp. 21-27.
Malfertheiner, P., et al., “Current Concepts in the Management ofHelicobacter pyloriInfection-The Maastricht Feb. 2000 Consensus Report”, Aliment Pharmacol Ther, (2002), vol. 16, pp. 167-180.
PREVACID Package Insert, pp. 1-32.

Affiliated with

Also associated with

Rating

Salts of benzimidazole compound and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Salts of benzimidazole compound and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Salts of benzimidazole compound and use thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3783660